Literature DB >> 22737039

Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Aaron Y Lai1, Joanne McLaurin.   

Abstract

Accumulation of senile plaques consisting of amyloid-β peptide (Aβ) aggregates is a prominent pathological feature in Alzheimer's disease. Effective clearance of Aβ from the brain parenchyma is thought to regulate the development and progression of the disease. Macrophages in the brain play an important role in Aβ clearance by a variety of phagocytic and digestive mechanisms. Subpopulations of macrophages are heterogeneous such that resident microglia in the parenchyma, blood macrophages infiltrating from the periphery, and perivascular macrophages residing along cerebral vessels make functionally distinct contributions to Aβ clearance. Despite phenotypic similarities between the different macrophage subsets, a series of in vivo models have been derived to differentiate their relative impacts on Aβ dynamics as well as the molecular mechanisms underlying their activities. This review discusses the key findings from these models and recent research efforts to selectively enhance macrophage clearance of Aβ.

Entities:  

Year:  2012        PMID: 22737039      PMCID: PMC3380064          DOI: 10.2217/fnl.12.6

Source DB:  PubMed          Journal:  Future Neurol        ISSN: 1479-6708


  124 in total

1.  Dystrophic microglia in the aging human brain.

Authors:  Wolfgang J Streit; Nicole W Sammons; Amanda J Kuhns; D Larry Sparks
Journal:  Glia       Date:  2004-01-15       Impact factor: 7.452

Review 2.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

3.  Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.

Authors:  Wesley Farris; Sonja G Schütz; John R Cirrito; Ganesh M Shankar; Xiaoyan Sun; Ana George; Malcolm A Leissring; Dominic M Walsh; Wei Qiao Qiu; David M Holtzman; Dennis J Selkoe
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity.

Authors:  Kryslaine O Lopes; D Larry Sparks; Wolfgang J Streit
Journal:  Glia       Date:  2008-08-01       Impact factor: 7.452

5.  Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

Authors:  Donna M Wilcock; Amyn Rojiani; Arnon Rosenthal; Gil Levkowitz; Sangeetha Subbarao; Jennifer Alamed; David Wilson; Nedda Wilson; Melissa J Freeman; Marcia N Gordon; Dave Morgan
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

6.  Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy.

Authors:  Justin Zaghi; Ben Goldenson; Mohammed Inayathullah; Albert S Lossinsky; Ava Masoumi; Hripsime Avagyan; Michelle Mahanian; Michael Bernas; Martin Weinand; Mark J Rosenthal; Araceli Espinosa-Jeffrey; Jean de Vellis; David B Teplow; Milan Fiala
Journal:  Acta Neuropathol       Date:  2009-01-13       Impact factor: 17.088

7.  Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Authors:  J Sanchez-Ramos; S Song; V Sava; B Catlow; X Lin; T Mori; C Cao; G W Arendash
Journal:  Neuroscience       Date:  2009-06-14       Impact factor: 3.590

8.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

Review 9.  Amyloid precursor protein trafficking, processing, and function.

Authors:  Gopal Thinakaran; Edward H Koo
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

10.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  56 in total

1.  Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.

Authors:  Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Songlin Li; Vladimir Ljubimov; Michelle Moyseyev; David Daley; Dieu-Trang Fuchs; Michael Pham; Keith L Black; Altan Rentsendorj; Maya Koronyo-Hamaoui
Journal:  Brain       Date:  2015-06-06       Impact factor: 13.501

Review 2.  Energy metabolism and inflammation in brain aging and Alzheimer's disease.

Authors:  Fei Yin; Harsh Sancheti; Ishan Patil; Enrique Cadenas
Journal:  Free Radic Biol Med       Date:  2016-05-03       Impact factor: 7.376

Review 3.  Immunotherapeutic approaches for Alzheimer's disease.

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Neuron       Date:  2015-03-18       Impact factor: 17.173

Review 4.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

5.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

Review 6.  Phagocyte dysfunction, tissue aging and degeneration.

Authors:  Wei Li
Journal:  Ageing Res Rev       Date:  2013-06-04       Impact factor: 10.895

7.  Innate Immunity Stimulation via Toll-Like Receptor 9 Ameliorates Vascular Amyloid Pathology in Tg-SwDI Mice with Associated Cognitive Benefits.

Authors:  Henrieta Scholtzova; Eileen Do; Shleshma Dhakal; Yanjie Sun; Shan Liu; Pankaj D Mehta; Thomas Wisniewski
Journal:  J Neurosci       Date:  2017-01-25       Impact factor: 6.167

Review 8.  Developing therapeutic vaccines against Alzheimer's disease.

Authors:  Thomas Wisniewski; Eleanor Drummond
Journal:  Expert Rev Vaccines       Date:  2015-12-11       Impact factor: 5.217

9.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.

Authors:  Maya Koronyo-Hamaoui; Julia Sheyn; Eric Y Hayden; Songlin Li; Dieu-Trang Fuchs; Giovanna C Regis; Dahabada H J Lopes; Keith L Black; Kenneth E Bernstein; David B Teplow; Sebastien Fuchs; Yosef Koronyo; Altan Rentsendorj
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

10.  Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.

Authors:  Kakulavarapu V Rama Rao; Tammy Kielian
Journal:  Clin Exp Neuroimmunol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.